Fabiana Da Silva Alves, Ph.D.

Dr. Fabiana Da Silva Alves has over 15 years of experience in clinical research, developing, overseeing, and managing all phases of clinical trials in CNS, psychiatry, neurology, and immunology studies at AMC, Novartis, Janssen and MAPS where she pioneered and led Europe’s first-ever MDMA-assisted therapy trial for PTSD. Holding a Ph.D. in Clinical Neurosciences – Psychiatry, Dr. Da Silva Alves focuses on the strategic, operational, and scientific development of psychedelic studies, with an unwavering commitment to innovative therapies for mental health.